Ameritas Investment Partners, Inc. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 88 filers reported holding REVANCE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.3%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$95,075
-45.5%
8,289
+20.3%
0.00%
-42.9%
Q2 2023$174,361
-16.2%
6,889
+6.6%
0.01%
-12.5%
Q1 2023$208,109
-3.9%
6,4610.0%0.01%
-11.1%
Q4 2022$216,508
+50.4%
6,461
+20.5%
0.01%
+50.0%
Q3 2022$144,000
+94.6%
5,3620.0%0.01%
+100.0%
Q2 2022$74,000
-29.5%
5,3620.0%0.00%
-25.0%
Q1 2022$105,000
+19.3%
5,3620.0%0.00%
+33.3%
Q4 2021$88,000
-40.9%
5,3620.0%0.00%
-40.0%
Q3 2021$149,000
-6.3%
5,3620.0%0.01%
-16.7%
Q2 2021$159,000
+6.0%
5,3620.0%0.01%0.0%
Q1 2021$150,000
-1.3%
5,3620.0%0.01%
-14.3%
Q4 2020$152,000
+12.6%
5,3620.0%0.01%
+16.7%
Q3 2020$135,000
+9.8%
5,362
+6.9%
0.01%0.0%
Q2 2020$123,000
+105.0%
5,017
+24.2%
0.01%
+100.0%
Q1 2020$60,000
-1.6%
4,039
+7.1%
0.00%0.0%
Q4 2019$61,000
+24.5%
3,7710.0%0.00%
+50.0%
Q3 2019$49,0000.0%3,7710.0%0.00%0.0%
Q2 2019$49,000
+8.9%
3,771
+33.2%
0.00%0.0%
Q1 2019$45,000
-21.1%
2,8320.0%0.00%
-33.3%
Q4 2018$57,000
-18.6%
2,8320.0%0.00%0.0%
Q3 2018$70,000
-10.3%
2,8320.0%0.00%
-25.0%
Q2 2018$78,000
+11.4%
2,832
+24.6%
0.00%
+33.3%
Q1 2018$70,0000.0%2,272
+15.4%
0.00%0.0%
Q4 2017$70,000
+45.8%
1,9690.0%0.00%
+50.0%
Q3 2017$48,000
-7.7%
1,9690.0%0.00%
-33.3%
Q2 2017$52,000
+73.3%
1,969
+38.0%
0.00%
+200.0%
Q1 2017$30,0001,4270.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$42,779,00061.17%
Essex Woodlands Management, Inc. 3,342,047$91,739,00021.30%
Sio Capital Management, LLC 101,292$2,780,0001.54%
Fosun International Ltd 472,532$12,971,0000.66%
Rhenman & Partners Asset Management AB 203,181$5,577,0000.57%
ArrowMark Colorado Holdings LLC 1,804,275$49,527,0000.46%
ESSEX INVESTMENT MANAGEMENT CO LLC 87,355$2,398,0000.30%
FOX RUN MANAGEMENT, L.L.C. 18,477$507,0000.16%
Phoenix Investment Adviser LLC 2,400$66,0000.12%
Quinn Opportunity Partners LLC 33,100$909,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders